A Bioequivalence Study of PP3M in Patients With Schizophrenia

Abroad (travel likely)Recruiting

Conditions

Schizophrenia

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Beijing Anding Hospital Capital Medical University, Beijing, Beijing Municipality, China
Contact: Study coordinator (Gang Wang, M.D.) · adyyjg@163.com · 010-58303236
Contact: Principal Investigator (Gang Wang, M.D.)
Contact: Principal Investigator (Anning Li, M.D.)

Study leads

Gang Wang, M.D.
Principal Investigator
Beijing Anding Hospital Capital Medical University

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

TIS for Improving Cognitive Impairment Associated With Schizophrenia

Cognitive Impairment Associated With Schizophrenia (CIAS)

Abroad (travel likely)Recruiting

Changsha, China

MicroRNAs as Biomarkers in First Episode Schizophrenia

Schizophrenia Disorder · Schizophreniform Disorder · Schizoaffective Disorder

Abroad (travel likely)Recruiting

Glen Oaks, United States

tACS for Working Memory in Schizophrenia

Schizophrenia · Working Memory

Abroad (travel likely)Recruiting

Changsha, China

The Purpose of This Study is to Determine the Safety, Tolerability, and Pharmacokinetics of Brexpiprazole Long-acting Injection Following a Single Administration in Healthy Subjects/Patients With Schizophrenia.

Schizophrenia Disorders

Abroad (travel likely)RecruitingPHASE1

Beijing, China